Great Point Partners as of Sept. 30, 2022
Portfolio Holdings for Great Point Partners
Great Point Partners holds 40 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals (XENE) | 7.4 | $31M | 850k | 36.10 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 6.9 | $29M | 215k | 133.29 | |
| Point Biopharma Global | 6.6 | $28M | 3.6M | 7.73 | |
| Alpine Immune Sciences (ALPN) | 6.0 | $25M | 3.4M | 7.20 | |
| Travere Therapeutics (TVTX) | 5.7 | $24M | 966k | 24.64 | |
| Heron Therapeutics (HRTX) | 5.7 | $24M | 5.6M | 4.16 | |
| Kalvista Pharmaceuticals (KALV) | 5.4 | $23M | 1.6M | 14.51 | |
| Pliant Therapeutics (PLRX) | 5.2 | $22M | 1.0M | 20.89 | |
| Relmada Therapeutics (RLMD) | 4.5 | $19M | 510k | 37.02 | |
| Aclaris Therapeutics (ACRS) | 3.9 | $16M | 1.0M | 15.74 | |
| Vaxcyte (PCVX) | 3.5 | $14M | 600k | 24.00 | |
| Galapagos Nv Spon Adr (GLPG) | 3.1 | $13M | 306k | 42.64 | |
| Acumen Pharmaceuticals (ABOS) | 2.9 | $12M | 1.2M | 10.03 | |
| Alkermes SHS (ALKS) | 2.7 | $11M | 508k | 22.33 | |
| Seagen | 2.5 | $11M | 77k | 136.82 | |
| Bridgebio Pharma (BBIO) | 2.5 | $10M | 1.1M | 9.94 | |
| Cincor Pharma | 2.4 | $9.9M | 301k | 32.82 | |
| Ventyx Biosciences (VTYX) | 2.3 | $9.4M | 270k | 34.91 | |
| Tricida | 2.2 | $9.1M | 870k | 10.48 | |
| Rapt Therapeutics (RAPT) | 1.8 | $7.6M | 315k | 24.06 | |
| Urogen Pharma (URGN) | 1.7 | $7.3M | 873k | 8.32 | |
| Replimune Group (REPL) | 1.6 | $6.7M | 390k | 17.27 | |
| Madrigal Pharmaceuticals (MDGL) | 1.5 | $6.2M | 96k | 64.99 | |
| Milestone Pharmaceuticals (MIST) | 1.5 | $6.2M | 675k | 9.19 | |
| 89bio (ETNB) | 1.3 | $5.5M | 955k | 5.79 | |
| Generation Bio (GBIO) | 1.1 | $4.4M | 825k | 5.31 | |
| Ngm Biopharmaceuticals (NGM) | 1.0 | $4.1M | 316k | 13.08 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.9 | $3.8M | 492k | 7.76 | |
| Immunocore Hldgs Ads (IMCR) | 0.9 | $3.7M | 79k | 46.94 | |
| Larimar Therapeutics (LRMR) | 0.9 | $3.6M | 1.1M | 3.20 | |
| Precision Biosciences Ord | 0.8 | $3.5M | 2.7M | 1.30 | |
| Cymabay Therapeutics | 0.7 | $2.8M | 799k | 3.50 | |
| Pieris Pharmaceuticals (PIRS) | 0.5 | $2.3M | 2.0M | 1.15 | |
| Intercept Pharmaceuticals In | 0.4 | $1.5M | 105k | 13.95 | |
| Gracell Biotechnologies Sponsored Ads | 0.3 | $1.4M | 449k | 3.22 | |
| Magenta Therapeutics | 0.3 | $1.4M | 1.0M | 1.41 | |
| Nektar Therapeutics (NKTR) | 0.3 | $1.4M | 448k | 3.20 | |
| Day One Biopharmaceuticals I (DAWN) | 0.3 | $1.4M | 71k | 20.04 | |
| Aeglea Biotherapeutics | 0.3 | $1.3M | 2.5M | 0.53 | |
| Silence Therapeutics Ads (SLN) | 0.2 | $692k | 69k | 10.04 |
